Regulatory T-cells in autoimmune diseases: challenges, controversies and—yet—unanswered questions

CR Grant, R Liberal, G Mieli-Vergani, D Vergani… - Autoimmunity …, 2015 - Elsevier
Regulatory T cells (Tregs) are central to the maintenance of self-tolerance and tissue
homeostasis. Markers commonly used to define human Tregs in the research setting include …

Dissecting the heterogeneity in T-cell mediated inflammation in IBD

I Tindemans, ME Joosse, JN Samsom - Cells, 2020 - mdpi.com
Infiltration of the lamina propria by inflammatory CD4+ T-cell populations is a key
characteristic of chronic intestinal inflammation. Memory-phenotype CD4+ T-cell frequencies …

The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy

G Cammarota, G Ianiro, R Cianci, S Bibbò… - Pharmacology & …, 2015 - Elsevier
Over the past recent years, a great number of studies have been directed toward the
evaluation of the human host–gut microbiota interaction, with the goal to progress the …

Bacterial translocation as inflammatory driver in Crohn's disease

R Linares, R Francés, A Gutiérrez… - Frontiers in Cell and …, 2021 - frontiersin.org
Crohn's disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract
responsible for intestinal lesions. The multifactorial etiology attributed to CD includes a …

selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases

C Felice, A Lewis, A Armuzzi… - Alimentary …, 2015 - Wiley Online Library
Background A link between histone deacetylases (HDAC s) and intestinal inflammation has
been established. HDAC inhibitors that target gut‐selective inflammatory pathways …

The innate and adaptive immune system as targets for biologic therapies in inflammatory bowel disease

G Holleran, L Lopetuso, V Petito, C Graziani… - International journal of …, 2017 - mdpi.com
Inflammatory bowel disease (IBD) is an immune-mediated inflammatory condition causing
inflammation of gastrointestinal and systemic cells, with an increasing prevalence …

Mechanisms behind efficacy of tumor necrosis factor inhibitors in inflammatory bowel diseases

CM Olesen, M Coskun, L Peyrin-Biroulet… - Pharmacology & …, 2016 - Elsevier
Biological treatment with tumor necrosis factor (TNF) inhibitors is successful in the
management of inflammatory bowel disease (IBD). All TNF inhibitors antagonize the pro …

TNF‐α: a treatment target or cause of sarcoidosis?

KT Amber, R Bloom, U Mrowietz… - Journal of the European …, 2015 - Wiley Online Library
Sarcoidosis is a systemic granulomatous disease that affects numerous organs, commonly
manifesting at the lungs and skin. While corticosteroids remain the first line of treatment …

GITR+ regulatory T cells in the treatment of autoimmune diseases

MG Petrillo, S Ronchetti, E Ricci, A Alunno, R Gerli… - Autoimmunity …, 2015 - Elsevier
Autoimmune diseases decrease life expectancy and quality of life for millions of women and
men. Although treatments can slow disease progression and improve quality of life, all …

Control of tissue‐localized immune responses by human regulatory T cells

AM Pesenacker, R Broady… - European journal of …, 2015 - Wiley Online Library
Treg cells control immune responses to self and nonharmful foreign antigens. Emerging
data from animal models indicate that Treg cells function in both secondary lymphoid organs …